Interpace Biosciences, Inc.
(NASDAQ : IDXG)

( )
IDXG PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Servicestothe Health Industry
symbolcompany%chnglast%shortavg$volume
LHLaboratory Corp. of America Holdings 0.38%195.462.4%$132.28m
DGXQuest Diagnostics, Inc. 0.62%112.864.2%$106.23m
SYNHSyneos Health, Inc. -0.41%65.620.0%$21.52m
NRCNational Research Corp. -0.62%68.920.0%$1.84m
AMEHApollo Medical Holdings, Inc. -1.89%17.150.0%$0.96m
IDXGInterpace Biosciences, Inc. 5.26%8.8024.1%$0.72m
PLXProtalix Biotherapeutics, Inc. -5.49%3.2756.8%$0.30m
BASIBioanalytical Systems, Inc. -7.06%4.610.2%$0.26m
PMDPsychemedics Corp. 0.54%9.250.7%$0.20m

Company Profile

Interpace Biosciences, Inc. operates as an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay. The company was founded by John P. Dugan in 1987 and is headquartered in Parsippany, NJ.